Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03897270 · ClinicalTrials.gov registry record · NA

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

A NA study of Breast Carcinoma and Healthy Subject, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT03897270 is a NA study of Breast Carcinoma and Healthy Subject that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 400 participants, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03897270, a NA study of Breast Carcinoma and Healthy Subject, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This trial studies photoacoustic imaging of the breast in patients with breast cancer and healthy subjects. Dense breasts typically reduce the sensitivity of a mammography and also is associated with a higher risk of breast cancer. Photoacoustic tomography combines light and sound to provide more information about breast tissue.

Interventions

  • PROCEDURE Photoacoustic Imaging

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2018-10-25
Est. Completion 2026-02-25
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT03897270

The ClinicalTrials.gov registry entry for NCT03897270 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (48% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Photoacoustic Imaging is the first listed.

NCT03897270 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03897270 about?

NCT03897270 is a clinical study titled "Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects". This trial studies photoacoustic imaging of the breast in patients with breast cancer and healthy subjects. Dense breasts typically reduce the sensitivity of a mammography and also is associated with a higher risk of breast cancer. Photoacoustic tomography combines light and sound to provide more in...

What is the current status of trial NCT03897270?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2018-10-25. Estimated completion is 2026-02-25.

What conditions does trial NCT03897270 study?

This clinical trial studies the following conditions: Breast Carcinoma, Healthy Subject.

What interventions are being tested in trial NCT03897270?

The interventions under investigation include: Photoacoustic Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT03897270?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03897270 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.